< Back to situations

[ORGANIZATION]

EFFE

Featured in 2 tracked stories · first seen

Situations

[ACTIVE] [BUSINESS] [KR]

Hanmi Pharmaceutical obesity drug Epe/Effe launch

3 clusters · 10 sources · last updated

Latest: Hanmi Pharmaceutical to launch domestic obesity drug Effe

Hanmi Pharmaceutical is preparing to launch ‘Epe’ (also referred to as ‘Effe’), a domestically developed GLP-1 class obesity medication in South Korea. Having received approval as the country’s 45th new drug from the Min

Also covered in